ICON PLC
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $252.57
- Today's High:
- $259.62
- Open Price:
- $253.48
- 52W Low:
- $171.43
- 52W High:
- $268.07
- Prev. Close:
- $255.46
- Volume:
- 396738
Company Statistics
- Market Cap.:
- $20.99 billion
- Book Value:
- 107.076
- Revenue TTM:
- $7.90 billion
- Operating Margin TTM:
- 12.15%
- Gross Profit TTM:
- $2.22 billion
- Profit Margin:
- 6.45%
- Return on Assets TTM:
- 3.51%
- Return on Equity TTM:
- 6.02%
Company Profile
ICON PLC had its IPO on 1998-05-15 under the ticker symbol ICLR.
The company operates in the Healthcare sector and Diagnostics & Research industry. ICON PLC has a staff strength of 41,160 employees.
Stock update
Shares of ICON PLC opened at $253.48 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $252.57 - $259.62, and closed at $257.28.
This is a +0.71% increase from the previous day's closing price.
A total volume of 396,738 shares were traded at the close of the day’s session.
In the last one week, shares of ICON PLC have slipped by -2.06%.
ICON PLC's Key Ratios
ICON PLC has a market cap of $20.99 billion, indicating a price to book ratio of 1.9304 and a price to sales ratio of 2.0329.
In the last 12-months ICON PLC’s revenue was $7.90 billion with a gross profit of $2.22 billion and an EBITDA of $1.53 billion. The EBITDA ratio measures ICON PLC's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, ICON PLC’s operating margin was 12.15% while its return on assets stood at 3.51% with a return of equity of 6.02%.
In Q2, ICON PLC’s quarterly earnings growth was a negative -0.7% while revenue growth was a positive 4.4%.
ICON PLC’s PE and PEG Ratio
- Forward PE
- 15.625
- Trailing PE
- 42.3648
- PEG
- 0.3268
Its diluted EPS in the last 12-months stands at $6.03 per share while it has a forward price to earnings multiple of 15.625 and a PEG multiple of 0.3268. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ICON PLC’s profitability.
ICON PLC stock is trading at a EV to sales ratio of 2.6446 and a EV to EBITDA ratio of 16.6612. Its price to sales ratio in the trailing 12-months stood at 2.0329.
ICON PLC stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $17.11 billion
- Total Liabilities
- $2.76 billion
- Operating Cash Flow
- $0
- Capital Expenditure
- $32.14 million
- Dividend Payout Ratio
- 0%
ICON PLC ended 2024 with $17.11 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $17.11 billion while shareholder equity stood at $8.80 billion.
ICON PLC ended 2024 with $0 in deferred long-term liabilities, $2.76 billion in other current liabilities, 6676000.00 in common stock, $2.05 billion in retained earnings and $8.99 billion in goodwill. Its cash balance stood at $270.18 million and cash and short-term investments were $271.83 million. The company’s total short-term debt was $105,150,000 while long-term debt stood at $4.21 billion.
ICON PLC’s total current assets stands at $3.37 billion while long-term investments were $35.30 million and short-term investments were $1.65 million. Its net receivables were $2.94 billion compared to accounts payable of $46.92 million and inventory worth $0.
In 2024, ICON PLC's operating cash flow was $0 while its capital expenditure stood at $32.14 million.
Comparatively, ICON PLC paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $257.28
- 52-Week High
- $268.07
- 52-Week Low
- $171.43
- Analyst Target Price
- $277.71
ICON PLC stock is currently trading at $257.28 per share. It touched a 52-week high of $268.07 and a 52-week low of $268.07. Analysts tracking the stock have a 12-month average target price of $277.71.
Its 50-day moving average was $251.2 and 200-day moving average was $223.72 The short ratio stood at 3.99 indicating a short percent outstanding of 0%.
Around 71.7% of the company’s stock are held by insiders while 9859.9% are held by institutions.
Frequently Asked Questions About ICON PLC
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; and clinical research services, including biostatistics, clinical operations, clinical supplies management, covid-19, data management, decentralized & hybrid clinical solutions, endpoint adjudication services, interactive response technologies, investigator payments, medical affairs, medical writing and publishing, pharmacovigilance, and site and patient solutions. The company also provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. In addition, it offers commercial positioning, early phase, language, medical imaging, and strategic solutions, as well as clinical trial management, consulting, and contract staffing services. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.